These results indicate that full-length recombinant human ADPN with functional activity for the induction of AMPK and PPARα signaling pathways could be produced on a large-scale from egg white, and that the chicken bioreactor system could provide an economical source of recombinant human ADPN for the treatment of metabolic diseases. Here, ADIPOQ is linked to metabolic disease.